Term | Conceptual Definition |
| Active Grant | A grant meeting the following criteria:
1. Today's date is between the budget start and end dates.
2. The grant has an eRA System (IMPAC II) application status code of "Awarded. Non-fellowships only." or "Awarded. Fellowships only."
|
| Activity Code | A 3-character code used to identify a specific category of extramural research activity, applied to various funding mechanisms. NIH uses three funding mechanisms for extramural research awards: grants, cooperative agreements and contracts. Within each funding mechanism, NIH uses 3-character activity codes (e.g., F32, K08, P01, R01, T32, etc.) to differentiate the wide variety of research-related programs NIH supports. A comprehensive list of activity codes may be found on the Types of Grant Programs Web page. |
| Administrative IC | The NIH Institute or Center to which the Center for Scientific Review (CSR) routes NIH grant applications for a funding decision. An I/C may request to change this assignment if the application is more suited to another I/C. Also referred to as primary assignment. |
| Administrative Supplement | A request for (or the award of) additional funds during a current project period to provide for an increase in costs due to unforeseen circumstances. All additional costs must be within the scope of the peer reviewed and approved project.
|
| Application Types | Type l New
Type 2 Competing continuation (a.k.a. renewal, re-competing)
Type 3 Competing Revision/Administrative Supplement Application for for additional (supplemental) support to cover increased costs (non-competing administrative supplement) or to expand the scope of work (competing revision)
Type 4 Extension- Request for additional years of support beyond the years previously awarded. Used only for select programs
Type 5 Non-competing continuation
Type 6 Successor-In-Interest
Type 7 Change of grantee institution
Type 8 Change of NIH awarding IC for a non-competing record
Type 9 Change of NIH awarding IC for a Renewal application
Amended - See Resubmission
Contract Types - See Contract Transaction Types |
| Award | The provision of funds by NIH, based on an approved application and budget or progress report, to an organizational entity or an individual to carry out a project or activity.
|
| Awarding IC | The NIH Institute or Center responsible for the award, administration, and monitoring of grant supported activities.
|
| Bilateral Agreement | A general science agreement between the U.S. and a foreign country. Grant applications from institutions in these countries that have been recommended for approval by the scientific review group are given special funding consideration by Council.
|
| Biomedical Research and Development Price Index. | Measures real annual changes in the prices of items and services required for research and development (R&D) activities.
|
| Biomedical Research Support Grants | Grants to strengthen, balance, and stabilize supported biomedical and behavioral research programs through flexible funds that permit institutions to respond quickly and effectively to emerging needs and opportunities; to enhance creativity and innovation, to support pilot studies, and to improve research resources.
|
| Biotechnology Research Centers | A research center funding mechanism. Grants to support regional and national access to the sophisticated research instrumentation and technology needed to solve medical and clinical research problems that are beyond the purview of conventional means. Investigators on NIH grants share these expensive resources, which results in considerable savings to the government.
|
| Bridge Awards | Bridge awards provide continued but limited interim support (bridge funding) for meritorious investigators who just miss the funding cutoff and have minimal support from other sources. The continued funding will permit the PD/PI additional time to strengthen a resubmission application. A Bridge award recipient usually will receive an R56 award for a single year. Investigators may not apply for R56 grants. Applications for conversion to an R56 will be selected by IC staff from reviewed applications that fall at or near the payline margins. |
| Budget Authority | Legal authority to spend monies for programs, projects, or activities. Budget authority may be classified by the period (one-year, multiyear, no-year), the timing of congressional action (current or permanent), or manner of determining the amount available (definite or indefinite).
|
| Budget Period | The intervals of time (usually 12 months each) into which a project period is divided for budgetary and funding purposes.
|
| Buildings and Facilities | Funds appropriated to pay the cost of design, development, construction, repair, and improvement of capital facilities and related infrastructure.
|
| Cancer Education Grants | Grants to fund innovative cancer education programs that ultimately will contribute to decreasing cancer incidence, morbidity, and mortality and to improving the quality of life of cancer patients. As long as the proposed cancer education programs address a need not adequately fulfilled by other grant mechanisms available at the National Institutes of Health and they are focused on areas of particular interest to the National Cancer Institute, the educational tools can be diverse. The proposed programs can include short courses and the development of curricula in academic institutions; the organization of national seminars, and workshops; the education of community health care professionals, biomedical and clinical investigators, and members of the lay community; to the sponsorship of short-term research experiences; and the development of web-based curriculum, communication, and educational tools. |
| Clinical Research | Research with human subjects that is: 1. Patient-oriented research. Research conducted with human subjects (or on material of human origin such as tissues, specimens, and cognitive phenomena) for which an investigator (or colleague) directly interacts with human subjects. Excluded from this definition are in vitro studies that utilize human tissues that cannot be linked to a living individual. It includes: mechanisms of human disease, therapeutic interventions, clinical trials, development of new technologies 2. Epidemiological and behavioral studies. 3. Outcomes research and health services research. Studies falling under 45 CFR part 46.101(b) (4) (Exemption 4) are not considered clinical research by this definition. |
| Clinical Research Center | A research center funding mechanism. Grants to support clinical research in a specialized environment where each center is a discrete unit of research beds separated from the general care ward with specialized equipment and expert personnel necessary to provide a controlled environment and assist in the rapid transfer of basic research results to patient care.
|
| Co-Funding | Funding arrangement through which two or more Institutes or Centers share in the funding of a grant.
|
| Co-Investigator | An individual involved with the PD/PI in the scientific development or execution of a project. The co-investigator (collaborator) may be employed by, or be affiliated with, the applicant/grantee organization or another organization participating in the project under a consortium agreement. A co-investigator typically devotes a specified percentage of time to the project and is considered senior/key personnel. The designation of a co-investigator, if applicable, does not affect the PD/PI’s roles and responsibilities as specified in the NIH Grants Policy Statement (NIH GPS), nor is it a role implying multiple PD/PI. |
| Commitment Base | Funds used for noncompeting (type 5 or ongoing awards), typically 70-80 percent of the dollars spent for research project grants.
|
| Comparative medicine center | A research center funding mechanism. Grants to support the development of mammalian and non-mammalian models for research, or to make animal or biological materials resources available to all qualified investigators. |
| Competing Applications | New or renewal applications that must undergo initial peer review.
|
| Competing Continuation | An application requiring competitive peer review and Institute/Center action to continue beyond the current competitive segment (also known as a Renewal or Type 2).
|
| Competing Supplement | Formerly used NIH term replaced by the term revision.
|
| Competitive Segment | The initial project period recommended for support (in general, up to 5 years) or each extension of a project period resulting from a competing continuation award.
|
| Constant Dollars | Dollar amounts adjusted for inflation, based on buying power in a selected base year. The BRDPI is used to determine constant dollars from current dollars.
|
| Continuation | Financial or direct assistance for a second or subsequent budget period. |
| Contract (R&D) | An award instrument used to acquire from a non-federal party, by purchase, lease, or barter, property or services for the direct benefit or use of the Federal government. The same term may be used to describe a vendor relationship between a recipient and another party under a grant (to acquire routine goods and services); however, the recipient may use subaward to describe the contract under a grant relationship. |
| Cooperative clinical research grants | Grant awarded to multiple institutions where investigators are asked to follow common research protocols, because there are insufficient numbers of subjects available at a single institution to conduct a major clinical trial. NIH staff is substantially involved in the management of these awards.
|
| Cooperative Research and Development Agreement (CRDA) | Any agreement between one or more NIH laboratories and one or more non-Federal parties under which the PHS, through its laboratories, provides personnel, services, facilities, equipment, or other resources with or without reimbursement (but not funds to non-Federal parties) and the non-Federal parties provide funds, personnel, services, facilities, equipment, or other resources toward the conduct of specified research or development efforts which are consistent with the missions of the laboratory.
|
| Costs, Direct | Costs that can be specifically identified with a particular project or activity. |
| Costs, Direct, Awarded | Total NIH direct cost dollars awarded to a grant. |
| Costs, Direct, Requested | Principal Investigators request a funding level in their application for each year. These dollars are only direct costs and do not include the indirect cost associated with the organization where the research will be conducted. |
| Costs, Indirect | Costs that are incurred by a grantee for common or joint objectives and cannot be identified specifically with a particular project or program. |
| Costs, Indirect, Awarded
| Total NIH indirect cost dollars awarded to a grant.
|
| Costs, Total, Awarded
| Total NIH dollars awarded to a grant.
|
| Council Round
| At the NIH, there are at least three, and sometimes four, council rounds each fiscal year: October, January, May, and sometimes August. Application receipt dates, initial review dates, and council review dates all fall within one of these council rounds. Incoming grant applications all are assigned to a council round.
|
| Count (application/award/grant)
| Unless noted, the total number of applications/grants shown, excluding administrative supplements.
|
| Count, excluding administrative supplements. | See Count |
| Current dollars | Actual dollars awarded without adjustment for inflation.
|
| Data Universal Numbering System (DUNS) | A nine-digit number established and assigned by Dun and Bradstreet to uniquely identify a business entity. |
| Department | Codes used to eliminate variations in the department names within an institution. Department codes are only used for domestic institutions of higher education.
|
| Department Category | The department combining name for this is standardized and the official NIH name for the organization.
|
| Disaggregated Application
| An application with a portion (or subproject) funded as a separate grant.
|
| Dual assignment | Applications simultaneously assigned to two or more Institutes or Centers. The primary Institute has complete responsibility for administering and funding the application; a secondary IC assumes this responsibility only if the primary is unable or unwilling to support it.
|
| DUNS Number | See Data Universal Numbering System. |
| Extramural award | Funds provided by the NIH to researchers and organizations outside the NIH.
|
| Extramural research | Research supported by NIH through a grant, contract, or cooperative agreement.
|
| Fellowship | An NIH training program award where the NIH specifies the individual receiving the award. Fellowships comprise the F activity codes.
|
| 1 2 3 |
